Locally Advanced Cervical Cancer

Explore clinical trials studying Locally Advanced Cervical Cancer. Study availability and eligibility vary by location and protocol.

37 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Locally Advanced Cervical Cancer trial results

Completed

Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)

NCT03830866

Conditions: Locally Advanced Cervical Cancer
Locations: Research Site Phoenix, Arizona, United States

Research Site La Jolla, California, United States

Research Site Orange, California, United States

Research Site Fort Myers, Florida, United States

View all 117 locations

View Trial Details

Completed

Rectovaginal Fistula in Post-Radiotherapy Advanced Cervical Cancer Patients

NCT05059119

Conditions: Locally Advanced Cervical Cancer
Locations: Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital Banqiao District, New Taipei, Taiwan

View Trial Details

Completed

A Retrospective Analysis: Whether Five Factors Affect PFS in Patients With Locally Advanced Cervical Cancer

NCT05779111

Conditions: Locally Advanced Cervical Cancer, Radiotherapy
Locations: Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China

View Trial Details

Completed

Lymphatic Mapping for Image Guided Radiotherapy in Patients With LACC - a Feasibility Study

NCT05746156

Conditions: Locally Advanced Cervical Cancer
Locations: Amsterdam UMC University of Amsterdam Amsterdam, Netherlands

View Trial Details

Completed

Predictors of Para-aortic Lymph Node Metastasis of Cervical Cancer

NCT05717751

Conditions: Locally Advanced Cervical Cancer
Locations: Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

View Trial Details

Completed

Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer

NCT01230996

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
Locations: Saint Bartholomew's Hospital London, England, United Kingdom

Hammersmith Hospital London, England, United Kingdom

Royal Marsden - London London, England, United Kingdom

Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, United Kingdom

View Trial Details

Completed

A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer

NCT01217177

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
Locations: Novartis Investigative Site Rio de Janeiro, Brazil

Novartis Investigative Site Rio de Janeiro, Brazil

View Trial Details

Locally Advanced Cervical Cancer

Locally Advanced Cervical Cancer trial results

Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)

Rectovaginal Fistula in Post-Radiotherapy Advanced Cervical Cancer Patients

A Retrospective Analysis: Whether Five Factors Affect PFS in Patients With Locally Advanced Cervical Cancer

Lymphatic Mapping for Image Guided Radiotherapy in Patients With LACC - a Feasibility Study

Predictors of Para-aortic Lymph Node Metastasis of Cervical Cancer

Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer

A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer

Related conditions